| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 10/08/2013 | US8551986 Treatment of sequelae of psychiatric disorders |
| 10/08/2013 | US8551453 Aromatic triamide-lanthanide complexes |
| 10/08/2013 | US8551452 Uridine dietary supplementation compliance methods and use thereof |
| 10/08/2013 | US8551451 Combination vaccine with acellular pertussis |
| 10/08/2013 | US8551450 Targeting vector-phospholipid conjugates |
| 10/08/2013 | US8551449 Contrast agents |
| 10/08/2013 | CA2486307C Drug pre-targeting by means of bi-specific antibodies and hapten constructs comprising a carrier peptide and the active agent(s) |
| 10/08/2013 | CA2463739C Automated modular hyperpolarizers |
| 10/03/2013 | WO2013148710A1 Efficient synthesis of ethylenedicysteine-sugar conjugates for imaging and therapy |
| 10/03/2013 | WO2013148376A1 Acoustically responsive particles |
| 10/03/2013 | WO2013145830A1 Photoacoustic reagent, reagent group, and manufacturing method for same |
| 10/03/2013 | WO2013144604A1 Biotinidase resistant biotinyl compounds |
| 10/03/2013 | WO2013142961A1 Egfl7 targeting and/or binding polypeptides and methods for inhibiting angiogenesis |
| 10/03/2013 | US20130263296 Cancer imaging with therapy: theranostics |
| 10/03/2013 | US20130261710 Block copolymer (bcp) encapsulated nanoparticles and methods of use thereof |
| 10/03/2013 | US20130260014 Coated sensors and methods related thereto |
| 10/03/2013 | US20130259808 Multifunctional nanoparticles |
| 10/03/2013 | US20130259807 Cell culture screen for agents that control adipogenesis and myofibroblast differentiation |
| 10/03/2013 | US20130259805 Development and screening of contrast agents for in vivo imaging of parkinson's disease |
| 10/02/2013 | EP2645104A2 Single nanoparticle having a nanogap between a core material and a shell material, and manufacturing method thereof |
| 10/02/2013 | CN103333896A Nucleic acid aptamer LXL-1 of breast cancer cell MDA-MB-231 and application thereof |
| 10/02/2013 | CN103330950A Method for preparing Gd3<+> magnetic resonance imaging contrast agent with graphene oxide serving as carrier |
| 10/02/2013 | CN103330949A Preparation method of pegylation dendrimer/gold nanoparticles for blood pool and tumor CT imaging |
| 10/02/2013 | CN103330948A Tumor targeted living body rapid fluorescence imaging method of rare earth metal nanocluster |
| 10/02/2013 | CN103330938A Tumor targeting photosensitizers and preparation methods and applications of photosensitizers |
| 10/02/2013 | CN102552947B Cation microvesicle and preparation method thereof |
| 10/02/2013 | CN101948488B Ruthenium-selenium coordination compound and application thereof in preparing fluorescent probe and antineoplastic medicine |
| 10/01/2013 | US8546531 Methods and reagents for preparing multifunctional probes |
| 10/01/2013 | US8546326 low viscosity mixture of: a) at least one neutral diacyl lipid, such as a diacyl glycerol; b) at least one phospholipid, such as a phosphatidyl choline; c) at least one biotolerable solvent, such as an oxygen containing solvent; d) at least one GLP-1 analogue; wherein the pre-formulation forms |
| 10/01/2013 | US8546139 Protocols for making hepatocytes from embryonic stem cells |
| 10/01/2013 | US8546095 Methods for determination of calcineurin activity and uses in predicting therapeutic outcomes |
| 10/01/2013 | US8546092 One step nanosensor for single and multidrug resistance in acute coronary syndrome (ACS) |
| 10/01/2013 | US8546077 Prostaglandin E2 modulation and uses thereof |
| 10/01/2013 | US8545854 Tuberculosis vaccine with improved efficacy |
| 10/01/2013 | US8545814 Non-invasive localization of a light-emitting conjugate in a mammal |
| 10/01/2013 | US8545812 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 10/01/2013 | US8545811 Solid composition for the oral administration of dyes and diagnostic use thereof |
| 10/01/2013 | US8545810 Methods and compositions for treatment of ADD/ADHD, depression, memory problems and other conditions |
| 10/01/2013 | CA2535770C Method for detecting cancer cells and monitoring cancer therapy |
| 09/26/2013 | WO2013142817A2 Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo |
| 09/26/2013 | WO2013141092A1 Cancer metastasis marker and method for diagnosing cancer metastasis using same |
| 09/26/2013 | WO2013140300A1 Coloured solution in particular for use in surgical methods for the treatment of the bodies of humans or animals. |
| 09/26/2013 | WO2013140175A1 Apparatus and method for manipulating entrained particles |
| 09/26/2013 | US20130254910 Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof |
| 09/26/2013 | US20130254907 Humanized transgenic animal |
| 09/26/2013 | US20130253315 Marker or filler forming fluid |
| 09/26/2013 | US20130251777 Brachytherapy Seed |
| 09/26/2013 | US20130251641 Functionalized Magnetic Nanoparticles and Methods of Use Thereof |
| 09/26/2013 | US20130251640 Protease degradable polypeptides and uses thereof |
| 09/26/2013 | US20130251639 Novel Cyclodecapeptide Compounds For Use As Drugs |
| 09/26/2013 | US20130251638 Switchable Nucleic Acid Aptamer Probe and Uses Thereof in Tumor Living Cell Detection and in Vivo Detection |
| 09/26/2013 | US20130251637 Fluorescent compounds |
| 09/26/2013 | US20130251636 Mri contrast agent containing composite particles |
| 09/26/2013 | US20130251634 Methods and compositions for protection of cells and tissues from computed tomography radiation |
| 09/26/2013 | US20130251633 Systems, methods, and devices for ultrasonic assessment of cancer and response to therapy |
| 09/26/2013 | US20130251628 Ligands to radiation-induced molecules |
| 09/26/2013 | DE102012204769A1 Marker useful for angiographic examination of organ, vascular system or body region of patient for registration of images from different modalities, comprises capsule filled with first material, where receptacle is arranged on capsule |
| 09/26/2013 | DE102012204570A1 Material zur Verwendung in einer Magnetresonanzanlage, Verfahren zum Herstellen des Materials und Magnetresonanzanlage Material for use in a magnetic resonance apparatus, method for producing the material and magnetic resonance imaging |
| 09/26/2013 | DE102012204567A1 Material zur Verwendung in einer Magnetresonanzanlage, Verfahren zum Herstellen des Materials und Magnetresonanzanlage Material for use in a magnetic resonance apparatus, method for producing the material and magnetic resonance imaging |
| 09/25/2013 | EP2641914A1 Monoclonal antibody capable of recognizing human papilloma virus (hpv) l2 protein, and method for measuring hpv-neutralizing antibody titer using same |
| 09/25/2013 | EP2641616A2 Method for in vivo targeting of nanoparticles via bioorthogonal copper-free click chemistry |
| 09/25/2013 | CN103328496A Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis |
| 09/25/2013 | CN103328008A Agents for clearing biomolecules from circulation |
| 09/25/2013 | CN103316362A Fluorine-containing potential dual-function probe based on chitosan structure and preparation method thereof |
| 09/25/2013 | CN103316361A Stable nanoscale superparamagnetic iron oxide solution as well as preparation method and application thereof |
| 09/25/2013 | CN103316360A Application of P110 delta mutational inactivated mouse model |
| 09/25/2013 | CN103315945A Vascular embolic agent as well as injection device and application thereof |
| 09/25/2013 | CN103315944A Methods and devices for lymphatic targeting |
| 09/25/2013 | CN103315738A Material for use in a magnetic resonance system, method for producing the material and magnetic resonance system |
| 09/25/2013 | CN102196773B Molecular imaging |
| 09/24/2013 | US8541345 Compositions and methods for the identification and use of epigenetic markers useful in the study of normal and abnormal mammalian gametogenesis |
| 09/24/2013 | US8541008 Monoclonal antibody against an ALS1 protein that specifically binds an epitope in an N-terminal domain and which inhibits adherence of Candida albicans to endothelial cells. |
| 09/24/2013 | US8540968 Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof |
| 09/24/2013 | US8540966 Contrast agents endowed with high relaxivity |
| 09/24/2013 | US8540965 Single wall nanotube constructs and uses therefor |
| 09/24/2013 | US8540639 Ultrasonographic identification of a sentinel lymph node |
| 09/24/2013 | CA2682064C Compositions for targeted imaging and therapy |
| 09/19/2013 | WO2013138612A1 Synthesis and application of novel imaging agents conjugated to dpa 713 analogs for imaging inflammation |
| 09/19/2013 | WO2013137302A1 Lysine oligomer derivative and cartilage tissue marker made thereof |
| 09/19/2013 | WO2013135737A1 Compositions for dysphagia assessment |
| 09/19/2013 | WO2012155055A9 Integrin-targeted imaging of inflammation in vascular remodeling |
| 09/19/2013 | US20130245386 Identification of tissue for debridement |
| 09/19/2013 | US20130245357 Magnetic Nanoparticle Formulations, Methods for Making Such Formulations, and Methods for their Use |
| 09/19/2013 | US20130243700 Proteomic Antisense Molecular Shield and Targeting |
| 09/19/2013 | US20130243699 Biodegradable Magnetic Nanoparticles and Related Methods |
| 09/19/2013 | US20130243698 Radical polarizing agents for dynamic nuclear polarization |
| 09/19/2013 | US20130243697 Novel Chimeric Proteins and Methods for Using The Same |
| 09/19/2013 | US20130243696 Compositions and Methods for the Treatment of Traumatic Brain Injury |
| 09/19/2013 | US20130243695 Chemoembolisation |
| 09/19/2013 | US20130243694 Particles and contrast agent including the same for optical imaging |
| 09/19/2013 | US20130243691 Agents for the molecular imaging of serine-protease in human pathologies |
| 09/18/2013 | EP2637703A1 Colon screening by using magnetic particle imaging |
| 09/18/2013 | CN103314102A Galectin 9-secreting cell, production method for same, and application for same |
| 09/18/2013 | CN103313726A Identification and enrichment of cell subpopulations |
| 09/18/2013 | CN103303981A Ferroferric oxide nanoparticle as well as preparation method and application thereof |
| 09/18/2013 | CN103303905A Synthesis method of water-soluble derivative of lanthanide series metal loaded carbon nano material and application of water-soluble derivative |
| 09/18/2013 | CN103301483A Preparation of supramolecular dendritic nano aggregate for magnetic resonance imaging contrast |
| 09/18/2013 | CN103301482A Amphipathy tri-block polypeptide ICG (Indocyanine Green) loaded micelle and preparation method thereof |
| 09/18/2013 | CN103301481A Target nucleic acid drug delivery system and application thereof |
| 09/18/2013 | CN103301480A Method of creating zebra fish peristalsis model and screening prokinetic medicaments |